Scottish BioTech raises funds to make cancer therapies accessible

Quick Summary:

Edinburgh-based BioTech Lentitek Ltd has secured £700,000 in private funding to make cancer therapies more widely accessible.

The company is now aiming to expand its partnerships with leading therapeutic developers working to treat some of the world’s most challenging diseases.

Over the past six months, Lentitek has secured evaluation agreements with major contract manufacturing companies.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Patrick Killeen

Category: InvestingBusiness

Markets: United Kingdom

Topics: MedTech Investment

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-03-11 @ 06:59:43 (1 days ago)

News Timezone: GMT +8:00

News Source URL: businesscloud.co.uk

Language: English

Article Length: 324 words

Reading Time: 2 minutes read

Sentences: 10 lines

Sentence Length: 33 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © BusinessCloud

News ID: 26887095

View Article Analysis

About BusinessCloud

Main Topics: InvestingBusiness

Official Website: businesscloud.co.uk

Update Frequency: 1 posts per day

Year Established: 2016

Headquarters: United Kingdom

News Last Updated: 9 hours ago

Coverage Areas: United Kingdom

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #61

Publisher Details

Frequently Asked Questions